Pfizer Oncology is proud to introduce Cancer: Its Personal
May 25, 2011Web posted by PAF
Pfizer Oncology is proud to introduce Cancer: It&qpos;s Personal, a program to educate people with cancer, their caregivers and healthcare professionals about personalized medicine in oncology.
The way we look at cancer is changing. Advances in medical research have helped us to understand that cancer tumors have unique molecular characteristics, called biomarkers, which may help with the diagnosis, prognosis, and clinical treatment of cancer. In many cases, we're now taking a more bio-specific approach to the treatment of some types of cancer; meaning that we can test a tumor for biomarkers to see if a certain treatment may be more or less likely to work.
The goal of Cancer: It's Personal is to provide the cancer community with resources to have more informed conversations about personalized medicine and biomarker testing.
Your members can download these educational materials from our website, www.CancerItsPersonal.com, which currently include:
- Doctor Discussion Guide, which includes questions to help people have an informed conversation with their doctor about biomarker testing and targeted treatment options;
- Personalized Medicine Fact Sheet, offering details about a bio-specific approach to personalized medicine and its role in cancer treatment.
- Glossary of Terms, with key terms that can help people better understand conversations with cancer specialists (coming soon!)
Please make sure to come back and visit the site, as we will periodically refresh with new educational videos and links to resources, such as the Patient Resource Cancer Guide. The upcoming Cancer Guide edition, titled "Personalized Medicine: Biomarkers and Molecular Testing," will focus on the future of personalized medicine. It will be accessible in June and also can be downloaded at patientresource.net.
In addition, we invite you to tune in to a new Discovery Channel* patient educational program titled, "Getting Personal: The Shifting Landscape of Cancer Care." Produced with support provided by Pfizer Oncology, this feature aims to further highlight advances in personalized cancer care. It will air at 8:00 a.m. ET, on Saturday, June 4. In addition, the program can be accessed at www.discoverychannelpatienteducation.com.
* Check local listings.
Advocacy is critically important for raising awareness and educating people about cancer. For that reason, we feel it's imperative to involve your organization in this effort to get the cancer community to start a dialogue about the evolving role of personalized medicine and biomarker testing. We hope that you will share this information with your members.
